HIV阳性患者肾移植:单中心16年经验
该单中心16年经验总结120例HIV阳性肾移植,占美国同类受者约10%。早期排斥率高致移植物失败,经多学科团队及方案调整后,1年患者和移植物存活率均100%,3年分别为100%和96%。
要点
- HIV阳性肾移植经多学科团队和方案优化可获良好结局。
- 早期排斥率较高,需关注围手术期免疫抑制与监测。
- 抗逆转录病毒方案与长期存活相关,需个体化评估。
核心结论
- HIV阳性肾移植通过多学科团队和方案修改可取得优异的移植后结局。
研究设计与样本
- 单中心16年经验,共完成120例HIV阳性患者肾移植,占美国同类受者约10%。
主要发现
- 早期HIV移植中排斥率增加,常导致移植物失败。
- 经方案修改后,1年患者和移植物存活率均为100%,3年患者存活率100%、移植物存活率96%。
- 提供了抗逆转录病毒治疗方案与长期存活关联的患者水平分析。
临床怎么用
- 建议建立多学科团队,并基于经验修改候选者评估、供者选择、围手术期免疫抑制和移植后监测方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hahnemann University Hospital has performed 120 kidney transplantations in human immunodeficiency virus (HIV)-positive individuals during the last 16 years. Our patient population represents ∼10% of the entire US population of HIV-positive kidney recipients. In our earlier years of HIV transplantation, we noted increased rejection rates, often leading to graft failure. We have established a multidisciplinary team and over the years have made substantial protocol modifications based on lessons learned. These modifications affected our approach to candidate evaluation, donor selection, perioperative immunosuppression, and posttransplantation monitoring and resulted in excellent posttransplantation outcomes, including 100% patient and graft survival at 1 year and patient and graft survival at 3 years of 100% and 96%, respectively. We present key clinical data, including a granular patient-level analysis of the associations of antiretroviral therapy regimens with long-term survival, cellular and antibody-mediated rejection rates, and the causes of allograft failures. In summary, we provide details on the evolution of our approach to HIV transplantation during the last 16 years, including strategies that may improve outcomes among HIV-positive kidney transplantation candidates throughout the United States.
引用
- Malat GE, Boyle SM, Jindal RM, et al. Kidney Transplantation in HIV-Positive Patients: A Single-Center, 16-Year Experience. Am J Kidney Dis. 2018. PMID: 29705074. doi:10.1053/j.ajkd.2018.02.352
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。